14.62 -0.11 (-0.75%) | 07-26 16:00 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() ![]() ![]() |
|||
Targets | 6-month : | 17.77 ![]() |
1-year : | 20.76 ![]() |
Resists | First : | 15.22 ![]() |
Second : | 17.77 ![]() |
Pivot price | 14.49 ![]() |
|||
Supports | First : | 14.44 ![]() |
Second : | 13.97 |
MAs | MA(5) : | 14.52 ![]() |
MA(20) : | 14.48 |
MA(100) : | 15.97 ![]() |
MA(250) : | 17.94 ![]() |
|
MACD | MACD : | -0.2 ![]() |
Signal : | -0.2 ![]() |
%K %D | K(14,3) : | 47.9 ![]() |
D(3) : | 43.9 ![]() |
RSI | RSI(14): 49.4 ![]() |
|||
52-week | High : | 23.57 | Low : | 13.97 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ VREX ] has closed below upper band by 38.5%. Bollinger Bands are 21.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 15 - 15.08 | 15.08 - 15.14 |
Low: | 14.19 - 14.27 | 14.27 - 14.33 |
Close: | 14.5 - 14.63 | 14.63 - 14.73 |
Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.
Thu, 25 Jul 2024
(VREX) Proactive Strategies - Stock Traders Daily
Thu, 25 Jul 2024
Varex Imaging (VREX) to Release Quarterly Earnings on Thursday - Defense World
Sat, 20 Jul 2024
First Eagle Investment Management LLC Boosts Holdings in Varex Imaging Co. (NASDAQ:VREX) - MarketBeat
Fri, 19 Jul 2024
Empowered Funds LLC Makes New Investment in Varex Imaging Co. (NASDAQ:VREX) - Defense World
Fri, 19 Jul 2024
VREX (Varex Imaging) Price-to-Operating-Cash-Flow - GuruFocus.com
Thu, 18 Jul 2024
Sell Alert: 3 Stocks to Offload Near 52-Week Lows - Markets Insider
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Devices
|
|
Shares Out | 41 (M) |
Shares Float | 40 (M) |
Held by Insiders | 4.8 (%) |
Held by Institutions | 107.7 (%) |
Shares Short | 3,470 (K) |
Shares Short P.Month | 4,440 (K) |
EPS | 0.92 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 14.1 |
Profit Margin | 4.9 % |
Operating Margin | 3.7 % |
Return on Assets (ttm) | 3 % |
Return on Equity (ttm) | 7.5 % |
Qtrly Rev. Growth | -9.7 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 20.94 |
EBITDA (p.s.) | 2.32 |
Qtrly Earnings Growth | -70 % |
Operating Cash Flow | 98 (M) |
Levered Free Cash Flow | 94 (M) |
PE Ratio | 15.89 |
PEG Ratio | 4.6 |
Price to Book value | 1.03 |
Price to Sales | 0.69 |
Price to Cash Flow | 6.08 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |